New drug targets tough KRAS cancers in early trial
NCT ID NCT07148128
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 28 times
Summary
This study tests a new drug called WEF-001 in about 110 adults with advanced solid tumors (pancreatic, colorectal, lung, ovarian, bile duct, or bladder cancer) that have a KRAS gene mutation and have stopped responding to standard treatments. The goal is to check the drug's safety and see if it can shrink tumors. Participants receive WEF-001 alone, and the study is currently recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NEXT Oncology Dallas
RECRUITINGDallas, Texas, 75230, United States
Contact Email: •••••@•••••
Contact
-
Next Oncology, San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
Contact Email: •••••@•••••
Contact
-
Oxford University Hospital
RECRUITINGHeadington, Oxford, 0X3 9DU, United Kingdom
Contact
Contact
Contact
-
Princess Margareth Cancer Center
RECRUITINGToronto, Ontario, Canada
Contact
Conditions
Explore the condition pages connected to this study.